Visiting professor Daniel J Drucker giving the 2024 Peters Lecture for Yale Internal Medicine Grand Rounds! 👏Thank you for sharing the story of “The GLP-1 Era”✨

Why should you be a member of TOS? Read #WhyIAmAMemberMonday Jamy D. Ard, MD, FTOS post to learn why. #TOSMembers . Join or renew your membership today! ow.ly/EHto50QkoAB

The Obesity Society, OAC and the Obesity Medicine Association have issued a joint statement recommending that patients do not use compounded alternatives to GLP-1 medications in their efforts to lose weight. Read the statement.

The American Academy of Pediatrics (AAP) 3rd Annual Pediatric Obesity Management course - great discussion today with amazing colleagues! American Academy of Pediatrics Yale Pediatrics Yale School of Medicine @Yale Yale New Haven Hosp
aap.org/3rd-Annual-202…

June 4, 2021: FDA approves semaglutide for obesity treatment
June 4, 2022: we present results of tirzepatide for obesity treatment American Diabetes Association NEJM
June 4, 2023 & on... excited for what the future may bring for obesity treatment for our patients💫✨
nejm.org/doi/full/10.10…

Amazing experience to present at the Endocrine Society of Australia in Sydney on the future of anti-obesity pharmacotherapy! Thank you Dr StellaS and Prof Carolyn Allan for a fabulous welcome! The Obesity Society Ted Kyle Yale University Yale New Haven Hosp Yale UniversityMed @TheOpeEdProject Endocrine Society

Amazing to teach alongside colleagues and friends again this year (virtually) at the Obesity Treatment course! Currently speaking - Dr. Donna Ryan and Dr. Lee Kaplan 👏 #obesitycourse2022 Live Stream & Video Gallery:➡️web.cvent.com/event/51bf460b…

With drugs that are closing in on the effectiveness of #BariatricSurgery , we are entering into a new era in #ObesityCare . At the opening of #ObesityTreatment2022 , Lee Kaplan paints a compelling picture of this new era.
conscienhealth.org/2022/06/what-d…

Blackburn Lecture at this year's course, presented by Daniel J Drucker ! 👏👏
#obesitycourse2022 ➡️streaming now➡️ cvent.me/E3Pymyv

Obesity Treatment 2022: Innovations in Obesity Care. If you haven’t seen this course - you’re missing out !

cvent.me/E3Pymy

An important study✨demonstrating that physiology fights back resulting in weight regain when treatment is discontinued ➡️ pubmed.ncbi.nlm.nih.gov/35441470/ Dr Robert Kushner sean wharton Ted Kyle The Obesity Society AACE Endocrine Society SudoCheng

Ready, Willing and Abel - U Magazine - UCLA Health - Los Angeles, CA uclahealth.org/u-magazine/rea…

I’ve been here for less than an hour and have seen my first two Covid pneumonia cases in several months. Both cases ~ one year overdue for first booster.

The 35th Annual Blackburn Course in Obesity Medicine is just 6 weeks away - excited to teach alongside my colleagues and friends!✨➡️web.cvent.com/event/51bf460b… Yale School of Medicine Yale School of Medicineicine Yale Pediatrics Yale New Haven Hosp Ted Kyle The Obesity Society Endocrine Society AACE SudoCheng

FDA just approved tirzepatide, a novel GIP/GLP-1 receptor agonist, for the treatment of type 2 diabetes based on data from the SURPASS trials American Diabetes Association - DiabetesPro Yale School of Medicine
fda.gov/news-events/pr…

Amazing presentation by outstanding physician-scientist Barbara Kahn, MD for the Yale John Peters Professorship Lecture on the beneficial anti-diabetic and anti-inflammatory effects of PAHSAs 👏 Yale Internal Medicine Yale Stress Center @Yale The Obesity Society #WomenInMedicine

Dr. Kibbey from Yale delivers outstanding presentation Pennington Biomedical Research Center about How beta-cells sense glucose:
Lessons from the Ox and the Caterpillar. Dr. John Kirwan Leanne M. Redman, PhD Vance L. Albaugh, MD, PhD, FACS, FASMBS Pennington Biomedical Research Foundation American Diabetes Association - DiabetesPro Endocrine News Endocrine Society Ania M. Jastreboff, MD, PhD

Thanks to Dr. Ania M. Jastreboff, MD, PhD for presenting info on certification by SudoCheng to our AACE #AACEObesity2022